Your Cart ( 1 Item )

• Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%–5% Affected Body Surface Area
  August 2021 | Volume 20 | Issue 8 | Original Article | 829 | Copyright © August 2021
  Emil A. Tanghetti MD^a, Neal Bhatia MD^b, Scott Drew DO^c, Abby Jacobson MS PA-C^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs